Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB)


re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.

Related Programs

Diabetes, Digestive, and Kidney Diseases Extramural Research

Department of Health and Human Services


Allergy, Immunology and Transplantation Research

Department of Health and Human Services


Microbiology and Infectious Diseases Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: Not Available